| Literature DB >> 32434594 |
Xiangfei Sun1,2, Qi Zhao3,4, Yufeng Huo5, Jinfeng Zhou5, Fen Zhao5, Yimin Liu5, Yonghai Du5, Songxiong He5, Chao Liu5, Detian Jiang5, Wenyu Sun6.
Abstract
OBJECTIVE: Aortic arch replacement in acute type A aortic dissection patients remains the most challenging cardiovascular operation. Herein, we described our modified Y-graft technique using the Femoral Artery Bypass (FAB) and the One Minute Systemic Circulatory Arrest (OSCA) technique, and assessed the short-term outcomes of the patients.Entities:
Keywords: Acute type a aortic dissection; Femoral artery bypass; Modified Y-graft technique; One minute systemic circulatory arrest
Year: 2020 PMID: 32434594 PMCID: PMC7240991 DOI: 10.1186/s13019-020-01156-5
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Patient characteristics
| Characteristic | Value |
|---|---|
| Number of patients | 51 |
| Age, years | 46.3 ± 9.9 |
| Sex, men: women | 42:9 |
| Emergency operation | 49 (96.1%) |
| Marfan syndrome | 4 (7.8%) |
| Aortic valve regurgitation | 18 (35.3%) |
| Diabetes mellitus | 1 (2.0%) |
| Smoking, past or current | 41 (80.4%) |
| Hypertension | 48 (94.1%) |
| Renal dysfunction | 3 (5.9%) |
| Pulmonary disease | 1 (2.0%) |
| Ischemic coronary heart disease | 4 |
Data are reported as mean ± SD, median (interquartile range), or number (%)
Fig. 1Reconstruction of three branches using femoral artery bypass (FAB) technique. The construction of three bypasses: femoral artery-to-left common carotid artery bypass, femoral artery-to-left subclavian artery bypass and femoral artery-to-innominate artery bypass
Fig. 2One minute systemic circulatory arrest (OSCA) during the surgery. a The intraoperative stent was placed into the distal aortic arch. b The aortic arch was immediately cross-clamped after de-airing, which greatly shortened the duration of the hypothermic circulatory arrest to about 1 min. c The 8 mm graft was end-to-side anastomosed to the 12 mm graft (innominate artery). The free-end of the 12 mm graft was end-to-side anastomosed to the ascending graft in ideal site
Traditional Y-Graft techniques vs Modified Y-Graft techniques utilizing Femoral artery bypass (FAB)
| Variates | Traditional Y-Graft techniques | Modified Y-Graft techniques utilizing Femoral artery bypass ( |
|---|---|---|
| Operative variables | ||
| Perfusion and ischemic times, minutes | ||
| Cardiopulmonary bypass | 141 (118–183) [ | 236 (200–290) |
| 236.2 ± 52.5 [ | ||
| 239 ± 53.1 [ | ||
| 279 ± 82 [ | ||
| 273 ± 79 [ | ||
| Systemic circulatory arrest | 65 (51–84) [ | 20.6 ± 6.9 |
| 31.2 ± 6.6 [ | ||
| 78 ± 34 [ | ||
| 69 ± 22 [ | ||
| Aortic clamp | 53.9 ± 41.1 [ | 105 ± 25.7 |
| 144 ± 55 [ | ||
| 163 ± 54 [ | ||
| Cerebral circulatory arrest | 0 | 0 |
| Lowest nasopharyngeal/rectal temperature, °C | 22.0 °C (19.1–23.7) [ | 28 °C |
| 12.8 ± 2.2 °C (9.9–19.8) [ | ||
| 15.8 ± 2.1 °C (12.0–22.1) [ | ||
| 24.0 ± 2.2 °C [ | ||
| 16–20 °C [ | ||
| 23 °C [ | ||
| Concomitant aortic valve replacement | 40% [ | ( |
| 2.8% [ | ||
| Concomitant coronary artery bypass | 9% [ | ( |
| 2.8% [ | ||
| Outcomes | ||
| Operative mortality | 2% [ | ( |
| 4.6% [ | ||
| 4.7% [ | ||
| 4.9% [ | ||
| 6.8% [ | ||
| 2% [ | ||
| 6.8% [ | ||
| 6.8% [ | ||
| Neurologic dysfunction | 5% [ | ( |
| 9.4% [ | ||
| 9.8% [ | ||
| 14% [ | ||
| 5% [ | ||
| 9.1% [ | ||
| Respiratory support | >2 days 20–51% [ | >2 days ( |
| >5 days 5–30% [ | >5 days ( | |
| Acute renal failure | 11% [ | ( |
| 3.7% [ | ||
| 6% [ | ||
| 13.1% [ | ||
| 5.4% [ | ||
Data are reported as mean ± SD, median (interquartile range), or number (%). The superscript numbers are the sequence number of references
One minute systemic circulation arrest (OSCA)
| Variates | Modified Y-Graft techniques utilizing Femoral artery bypass (without OSCA, | Modified Y-Graft techniques utilizing Femoral artery bypass (with OSCA, | |
|---|---|---|---|
| Preoperative characteristics | |||
| Age, years | 46.5 ± 11.8 | 46.1 ± 8.3 | |
| Male sex | ( | ( | |
| Weight, Kg | 80.5 ± 13.4 | 80.8 ± 12.6 | |
| Marfan syndrome | ( | ( | |
| Aortic valve regurgitation | ( | ( | |
| Diabetes mellitus | ( | ( | |
| Smoking, past or current | ( | ( | |
| Hypertension | ( | ( | |
| Renal dysfunction | ( | ( | |
| Pulmonary disease | ( | ( | |
| Operative variables | |||
| Perfusion and ischemic times, minutes | |||
| Cardiopulmonary bypass | 236 (200–290) | 204 (169–246) | |
| Systemic circulatory arrest | 20.6 ± 6.9 | 1.6 ± 1.1 | |
| Aortic clamp | 105 ± 25.7 | 92.9 ± 35.2 | |
| Cerebral circulatory arrest | 0 | 0 | NA |
| Skin-to-skin time | 486 ± 51.3 | 432 ± 40.5 | |
| Lowest nasopharyngeal temperature, °C | 28 | 32 | NA |
| Concomitant aortic valve replacement | ( | ( | |
| Concomitant coronary artery bypass | ( | ( | |
| Outcomes | |||
| Operative mortality | ( | ( | |
| neurologic dysfunction | ( | ( | |
| Respiratory support | >2 days ( | >2 days ( | |
| >5 days ( | >5 days ( | ||
| Acute renal failure | ( | ( | |
NA not available. Data are reported as mean ± SD, median (interquartile range), or number (%)
Fig. 3Comparison of the operative variables between the modified Y-graft technique using FAB and modified Y-graft technique using FAB and OSCA. a, b The cardiopulmonary bypass time [236 (200–290) min, 204 (169–246) min, *p < 0.05] and systemic circulatory arrest time (20.6 ± 6.9 min, 1.6 ± 1.1 min, *p < 0.05) were significantly shortened after modified Y-graft technique using FAB+OSCA technique. c The aortic clamp time had no significant difference between the two groups (105 ± 25.7 min, 92.9 ± 35.2 min, p > 0.05). d The percentage of concomitant aortic valve replacement was lower in the patients with FAB+OSCA techniques (34.8, 10.7%, p < 0.05). The error bars in A-C represent mean ± Std. deviation. *p < 0.05, t-test
Fig. 4Comparison of the outcomes between the modified Y-graft technique using FAB and modified Y-graft technique using FAB and OSCA. The 28 patients who underwent modified Y-graft technique using FAB+OSCA had an operative mortality of 7.1% and the morbidity of neurological dysfunction was 3.6% (b), and these data were statistically equal to the patients who underwent only FAB. Furthermore, the FAB+OSCA patients had significantly shorter respiratory support duration (a) and lower morbidity due to acute renal failure (b). *p < 0.05, chi-square test